Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Effects of firocoxib, meloxicam, and tepoxalin on prostanoid and leukotriene production by duodenal mucosa and other tissues of osteoarthritic dogs.

Punke JP, Speas AL, Reynolds LR, Budsberg SC.

Am J Vet Res. 2008 Sep;69(9):1203-9. doi: 10.2460/ajvr.69.9.1203.

PMID:
18764695
3.

Effects of firocoxib, meloxicam, and tepoxalin administration on eicosanoid production in target tissues of healthy cats.

Goodman LA, Torres BT, Reynolds LR, Budsberg SC.

Am J Vet Res. 2010 Sep;71(9):1067-73. doi: 10.2460/ajvr.71.9.1067.

PMID:
20807147
4.

In vivo effects of meloxicam and aspirin on blood, gastric mucosal, and synovial fluid prostanoid synthesis in dogs.

Jones CJ, Streppa HK, Harmon BG, Budsberg SC.

Am J Vet Res. 2002 Nov;63(11):1527-31.

PMID:
12428662
6.

Effects of firocoxib and tepoxalin on healing in a canine gastric mucosal injury model.

Goodman L, Torres B, Punke J, Reynolds L, Speas A, Ellis A, Budsberg S.

J Vet Intern Med. 2009 Jan-Feb;23(1):56-62. doi: 10.1111/j.1939-1676.2008.0226.x.

7.

Cyclooxygenase expression and prostanoid production in pyloric and duodenal mucosae in dogs after administration of nonsteroidal anti-inflammatory drugs.

Wooten JG, Blikslager AT, Ryan KA, Marks SL, Law JM, Lascelles BD.

Am J Vet Res. 2008 Apr;69(4):457-64. doi: 10.2460/ajvr.69.4.457.

PMID:
18380576
8.

In vitro effects of meloxicam on metabolism in articular chondrocytes from dogs with naturally occurring osteoarthritis.

Budsberg SC, Stoker AM, Johnston SA, Liska W, Reno LR, Cook JL.

Am J Vet Res. 2013 Sep;74(9):1198-205. doi: 10.2460/ajvr.74.9.1198.

PMID:
23977892
9.

Effect of nonsteroidal anti-inflammatory drugs with varied cyclooxygenase-2 selectivity on cyclooxygenase protein and prostanoid concentrations in pyloric and duodenal mucosa of dogs.

Wooten JG, Blikslager AT, Marks SL, Law JM, Graeber EC, Lascelles BD.

Am J Vet Res. 2009 Oct;70(10):1243-9. doi: 10.2460/ajvr.70.10.1243.

PMID:
19795939
10.

Comparison of tepoxalin, carprofen, and meloxicam for reducing intraocular inflammation in dogs.

Gilmour MA, Lehenbauer TW.

Am J Vet Res. 2009 Jul;70(7):902-7. doi: 10.2460/ajvr.70.7.902.

PMID:
19566476
11.
12.

Effect of flunixin meglumine and firocoxib on ex vivo cyclooxygenase activity in horses undergoing elective surgery.

Duz M, Parkin TD, Cullander RM, Marshall JF.

Am J Vet Res. 2015 Mar;76(3):208-15. doi: 10.2460/ajvr.76.3.208.

PMID:
25710756
13.

Meloxicam: influence on arachidonic acid metabolism. Part II. In vivo findings.

Engelhardt G, Bögel R, Schnitzler C, Utzmann R.

Biochem Pharmacol. 1996 Jan 12;51(1):29-38.

PMID:
8534265
14.

Acute and chronic effects of tepoxalin on kidney function in dogs with chronic kidney disease and osteoarthritis.

Lomas AL, Lyon SD, Sanderson MW, Grauer GF.

Am J Vet Res. 2013 Jun;74(6):939-44. doi: 10.2460/ajvr.74.6.939.

PMID:
23718664
15.
16.

Clinical evaluation of firocoxib and carprofen for the treatment of dogs with osteoarthritis.

Pollmeier M, Toulemonde C, Fleishman C, Hanson PD.

Vet Rec. 2006 Oct 21;159(17):547-51.

PMID:
17056650
17.

Antiinflammatory effect of tepoxalin: blood and synovial tissue studied in patients with knee arthrosis.

Willburger RE, Wittenberg RH, Schmidt K, Kleemeyer KS, Peskar BA.

Acta Orthop Scand. 1998 Jun;69(3):295-300.

PMID:
9703407
20.

Efficacy and safety of firocoxib in the management of canine osteoarthritis under field conditions.

Hanson PD, Brooks KC, Case J, Conzemius M, Gordon W, Schuessler J, Shelley B, Sifferman R, Drag M, Alva R, Bell L, Romano D, Fleishman C.

Vet Ther. 2006 Summer;7(2):127-40.

PMID:
16871495

Supplemental Content

Support Center